Vimarsana
Biggest News Aggregation in the World

Page 4 - Recode Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Recode Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Recode Therapeutics Today - Breaking & Trending Today

Pfizer CEO Signs Drug Companies' Open Letter Opposing Abortion Pill Decision - Vimarsana News

Pfizer CEO Signs Drug Companies' Open Letter Opposing Abortion Pill Decision

Pfizer's CEO signed an open letter Monday advocating for the reversal of a judge's decision to suspend FDA approval of the abortion pill, Reuters reported.

Pfizer, hundreds of US drugmakers call for reversal of Texas abortion pill ruling - Vimarsana News

Pfizer, hundreds of US drugmakers call for reversal of Texas abortion pill ruling

Over 300 biotech and pharmaceutical industry executives, including Pfizer Inc CEO Albert Bourla, signed an open letter on Monday calling for reversal of a federal judge's decision to suspend sales of the abortion pill mifepristone.

Hundreds of US drugmakers, including Pfizer, call for reversal of sales suspension of abortion pill - Vimarsana News

Hundreds of US drugmakers, including Pfizer, call for reversal of sales suspension of abortion pill

Pfizer's CEO, along with 300 other pharmaceutical and biotech executives, signed a letter calling for the reversal of a ruling that suspended the sales of abortion pill mifepristone.

Pfizer, hundreds of U.S. drug makers call for reversal of Texas abortion pill ruling - Vimarsana News

Pfizer, hundreds of U.S. drug makers call for reversal of Texas abortion pill ruling

Last week’s ruling undermines the FDA’s authority, the letter’s authors wrote, adding that it ignores decades of scientific evidence and legal precedent

300 biotech CEOs call for reversal on abortion pill ban - Vimarsana News

300 biotech CEOs call for reversal on abortion pill ban

Pfizer’s Albert Bourla is among the CEOs who signed a letter against suspending mifepristone, citing its impact on the FDA and the biotech industry.